Navigation Links
Molecular Devices Releases Breakthrough TUNE Technology, Now Part of the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform
Date:9/2/2011

SUNNYVALE, Calif., Sept. 2, 2011 /PRNewswire/ -- Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced the addition of the TUNE detection cartridge to the SpectraMax Paradigm Multi-Mode Microplate Detection Platform. The breakthrough technology of TUNE with wavelength flexibility in a monochromator device and up to 10x the sensitivity will benefit both the research and screening markets.

(Logo:  http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)

The SpectraMax Paradigm Detection Platform is the only user upgradeable microplate reader on the market today. It allows the user to read what they want, when they want. Now, with the TUNE detection cartridge, the Paradigm system is the most flexible instrument available. The patent pending Spectral Optimization Wizard in SoftMax® Pro software reduces the assay set up time by more than 50% with simultaneous scanning of excitation and emission spectrums.

Flexibility for Research

For the researchers who need the wavelength flexibility of a monochromator in fluorescent applications, TUNE will offer unmatched sensitivity allowing them to test new assays and further advance their research. The flexibility of the Paradigm platform and ability to easily add future options, makes it a great investment for their labs.

Speed of Paradigm with Sensitivity of TUNE, Ideal for Screening

The TUNE cartridge enables monochromator-like wavelength flexibility without compromising on sensitivity. The Paradigm platform is built with on-the-fly detection for reduced read times, plate format of up to 1536-wells, dual PMTs, and was designed with automation in mind, all important features for high throughput. Use of the TUNE cartridge with the Paradigm instrument will meet the needs of screeners with high sensitivity and throughput demands.

"We are extremely excited about our TUNE technology, which provides unmatched fluorescence sensitivity with wavelength flexibility. It will open new possibilities to our customers and is a great addition to the SpectraMax Paradigm platform," said Mikey Kindler, Senior Director of BioResearch Marketing.

About Molecular Devices, LLC

At Molecular Devices we have one focus—our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire creative, best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dedicated follow-on support. Understanding your laboratory workflow is our top priority, and we direct product development toward solving your unique issues. Our instruments offer a full spectrum of detection technologies and meet all throughput needs—from dedicated, single-readout devices to multi-readout systems. Our goal is to deliver highly relevant analytical products to detect biology, decode data, and drive discovery. With headquarters in Silicon Valley and offices around the globe, we support and enrich efforts of the international BioResearch, BioPharma, and BioTesting communities. Visit us today at www.MolecularDevices.com.

Molecular Devices products are for Research Use Only. Not for use in diagnostic procedures.

The trademarks mentioned herein are the property of Molecular Devices, LLC, or their respective owners.

© 2011. Molecular Devices, LLC


'/>"/>
SOURCE Molecular Devices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pathologists Gather to Focus on Advances in Molecular Testing, Digital Imaging, and Biospecimens
2. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
3. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
4. Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation
5. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
6. Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
7. Amsterdam Molecular Therapeutics Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients
8. Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
9. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
10. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
11. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):